Avalon Pharma has developed an expansive portfolio of pharmaceutical products.
For more information please select from any of the below categories:
Avalon Pharma has launched 146 SKU's through its own research and development efforts and currently has 24 molecules in its development pipeline. Avalon Pharma operates three state-of-the-art manufacturing facilities in Riyadh's second industrial zone:
Avalon Pharma 1
Manufactures topical preparations such as topical creams, lotions, other topical solutions, and cosmetic products. This factory produces suppositories and oral tablets and capsules on a small scale.
Avalon Pharma 2
Fully equipped with an R&D center, a complete analytical and development laboratory with a provision for establishing a large scale oral solid manufacturing facility.
Avalon Pharma 3
Fully operational and has the capability to produce disinfectants, sanitizers, mouthwashes and large volume hygiene products.
Research & Development
Avalon Pharma has secured the resources to expand its research and development (R&D) activities. The company's R&D team focuses on developing innovative products and complex formulations that will allow Avalon Pharma to meet the needs and expectations of customers.
The R&D team is responsible for product formulation, process design and monitoring of bio-equivalency testing for all segments. Beyond product development, the team also works to manage the life-cycle of existing products and to improve manufacturing techniques.